Formulation and Characterization of Nasal Sprays
Butorphanol nasal spray* Desmopressin nasal spray' pH Osmolality(mOsmol/Kg) or Osmolarity (mOsmol/L) 57 Not available 5.5 372 or 742 rnOsrnol/Kg for 5 or 20 mg dose respecfively 5 3.5-6 420-470 rnOsrn01/L Not available Not available 10 JUNE 2012 Formulation and characterization of nasal sprays An examination of nasal spray form ulafion ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- desmopressin ในกรณี nocturnal polyuria และ primary
- no item description
- formulation and characterization of nasal sprays
- desmopressin v2 final mspca angell
- new zealand data sheet medsafe
- development and evaluation of a composite dosage form
- 1 00188 cade oil goodron bulk 600 70
- scientifi article a pharmacokinetic study of midazolam in
- effectiveness of a nonsteroidal anti inflammatory drug for
- importance of different novel nasal drug delivery system a
Related searches
- signs and symptoms of crps
- rights and responsibilities of workers
- signs and symptoms of rsd
- advantages and disadvantages of relationships
- synonyms and definitions of words
- goals and purposes of education
- the role of culture in teaching and learning of english as a foreign language
- dangers of nasal swabs
- happiness is the meaning and the purpose of life the whole aim and end of human
- signs of nasal allergies
- similarities and differences of debit and credit
- indirect characterization of lennie small